Related Articles
Co-delivery of doxorubicin and pH-sensitive curcumin prodrug by transferrin-targeted nanoparticles for breast cancer treatment
Aptamer‑based therapy for targeting key mediators of cancer metastasis (Review)
Transferrin-conjugated doxorubicin-loaded lipid-coated nanoparticles for the targeting and therapy of lung cancer
Targeting Ku protein for sensitizing of breast cancer cells to DNA-damage
Knockdown of ROS1 gene sensitizes breast tumor growth to doxorubicin in a syngeneic mouse model